Ya‐Wen Ho

472 total citations
15 papers, 361 citations indexed

About

Ya‐Wen Ho is a scholar working on Geriatrics and Gerontology, Physiology and Oncology. According to data from OpenAlex, Ya‐Wen Ho has authored 15 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 6 papers in Physiology and 5 papers in Oncology. Recurrent topics in Ya‐Wen Ho's work include Frailty in Older Adults (7 papers), Nutrition and Health in Aging (6 papers) and Esophageal and GI Pathology (3 papers). Ya‐Wen Ho is often cited by papers focused on Frailty in Older Adults (7 papers), Nutrition and Health in Aging (6 papers) and Esophageal and GI Pathology (3 papers). Ya‐Wen Ho collaborates with scholars based in Taiwan. Ya‐Wen Ho's co-authors include Po‐Lin Kuo, Meng‐Chi Yen, Deng‐Chyang Wu, Jaw‐Yuan Wang, Cheng‐Ying Wu, Jung‐Yu Kan, Ya‐Ling Hsu, Wen‐Chi Chou, Shu‐Fang Jian and Jen‐Yu Hung and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Radiation Oncology*Biology*Physics and Journal of Cellular Physiology.

In The Last Decade

Ya‐Wen Ho

15 papers receiving 361 citations

Peers

Ya‐Wen Ho
Meili Ma China
K. A. Kern United States
N. Lee United States
Ya‐Wen Ho
Citations per year, relative to Ya‐Wen Ho Ya‐Wen Ho (= 1×) peers Kaitao Yuan

Countries citing papers authored by Ya‐Wen Ho

Since Specialization
Citations

This map shows the geographic impact of Ya‐Wen Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Wen Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Wen Ho more than expected).

Fields of papers citing papers by Ya‐Wen Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Wen Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Wen Ho. The network helps show where Ya‐Wen Ho may publish in the future.

Co-authorship network of co-authors of Ya‐Wen Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Wen Ho. A scholar is included among the top collaborators of Ya‐Wen Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Wen Ho. Ya‐Wen Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ho, Ya‐Wen, et al.. (2022). Optimal Frailty Dimensions for Assessing Frailty and Predicting Chemotherapy Adverse Events in Older Taiwanese Cancer Patients. Frontiers in Medicine. 9. 828865–828865. 3 indexed citations
2.
Hung, Yu‐Shin, Hung Chang, Po‐Nan Wang, et al.. (2022). Pretreatment frailty is an independent prognostic factor among elderly patients with B‐cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in Taiwan. Asia-Pacific Journal of Clinical Oncology. 19(1). 62–70. 2 indexed citations
3.
Chou, Wen‐Chi, Cheng-Chou Lai, Chia‐Yen Hung, et al.. (2022). Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy. Cancer Control. 29. 2895463324–2895463324. 10 indexed citations
4.
Huang, Yung‐Hsin, Yu‐Shin Hung, Cheng-Chou Lai, et al.. (2021). Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy. Anticancer Research. 41(10). 5213–5222. 6 indexed citations
5.
Chen, Shih‐Ying, Wen‐Chi Chou, Yung‐Chang Lin, et al.. (2021). Performance of two frailty screening tools among patients with cancer in Taiwan. Biomedical Journal. 45(2). 361–369. 11 indexed citations
6.
Tseng, Chen‐Kan, Po‐Jung Su, Chia‐Yen Hung, et al.. (2021). Paclitaxel and CarboplatinVersusCisplatin and 5-Fluorouracil in Concurrent Chemoradiotherapy in Patients With Esophageal Cancer. In Vivo. 35(6). 3391–3399. 6 indexed citations
7.
Ho, Ya‐Wen, Woung‐Ru Tang, Shih‐Ying Chen, et al.. (2021). Association of frailty and chemotherapy-related adverse outcomes in geriatric patients with cancer: a pilot observational study in Taiwan. Aging. 13(21). 24192–24204. 22 indexed citations
8.
Chou, Wen‐Chi, Pei‐Hung Chang, Ping‐Tsung Chen, et al.. (2020). Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). 602–611. 24 indexed citations
9.
Ho, Ya‐Wen, Kun‐Yun Yeh, Chia‐Yen Hung, et al.. (2020). Impact of early nutrition counseling in head and neck cancer patients with normal nutritional status. Supportive Care in Cancer. 29(5). 2777–2785. 27 indexed citations
10.
Tsai, Ming‐Ju, Wei‐An Chang, Pei-Hsun Tsai, et al.. (2017). Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells. International Journal of Molecular Sciences. 18(7). 1353–1353. 50 indexed citations
11.
Kan, Jung‐Yu, Meng‐Chi Yen, Jaw‐Yuan Wang, et al.. (2016). Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer. Oncotarget. 7(21). 31336–31349. 66 indexed citations
12.
Yen, Meng‐Chi, Ya‐Ling Hsu, En‐Shyh Lin, et al.. (2015). Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer. Oncology Reports. 35(3). 1356–1364. 32 indexed citations
13.
Hsu, Ya‐Ling, Jen‐Yu Hung, Eing‐Mei Tsai, et al.. (2015). Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9. Oncology Reports. 34(6). 2889–2900. 31 indexed citations
14.
Ho, Ya‐Wen & Chih‐Cheng Lin. (2015). A Preliminary Study on Taiwanese EFL Adolescents' Perceptions of Mobile-Assisted Post-Reading Tasks. 11. 309–313. 1 indexed citations
15.
Kan, Jung‐Yu, Deng‐Chyang Wu, Fang‐Jung Yu, et al.. (2014). Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1. Journal of Cellular Physiology. 230(8). 1883–1894. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026